|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
9/12/2007 8:06:38 AM
CAMPBELLVILLE, ON, Sept. 11 /CNW/ - NIR Diagnostics Inc. (TSX Venture:
NID), a leading-edge developer of near-infrared medical instruments, today
announced that Shaklee Corporation of Pleasanton, California, advised NIR
Diagnostics on September 8, 2007 that it is Shaklee's position that the
conditions were not met that would entitle NIR Diagnostics to a $1,000,000
success fee in connection with the delivery of the in-vivo food supplement
prototype device using NIR Diagnostics' proprietary infrared technology, as
stipulated in the strategic alliance agreement announced on August 9, 2006.
|
|
|
|
|
|
|
|
|
|
|